Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
15.84
+1.01 (6.81%)
Jun 27, 2025, 4:00 PM - Market closed

Sionna Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
698---
Enterprise Value
353---
Debt / Equity Ratio
0.030.060.31-
Quick Ratio
28.3114.164.7910.01
Current Ratio
28.7314.494.8810.16
Return on Equity (ROE)
--61.44%-83.45%-
Return on Assets (ROA)
--37.10%-45.16%-
Return on Capital (ROIC)
--39.90%-50.84%-
Buyback Yield / Dilution
-277.77%-31.56%-13.80%-
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q